Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 3;6(1):e2244975.
doi: 10.1001/jamanetworkopen.2022.44975.

Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19

William Encinosa  1   2 , Kyung Moon  3   4 , Jessica Figueroa  5 , Youssef Elias  6
Affiliations

Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem Inflammatory Syndrome in Children vs COVID-19

William Encinosa et al. JAMA Netw Open. .

Abstract

Importance: Multisystem inflammatory syndrome in children (MIS-C) causes severe inflammation of multiple organ systems after SARS-CoV-2 infection. During the pandemic, surveillance reporting of MIS-C was voluntary, with likely underreporting. For a rare syndrome like MIS-C, numerous data are needed to explore the disease in greater detail.

Objective: To use large all-payer billing data and the new International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Clinical Modification (ICD-10-CM) code for MIS-C to compare outcomes across MIS-C and COVID-19 over all 4057 hospitals in 31 states.

Design, setting, and participants: A retrospective cross-sectional study of all COVID-19 and MIS-C hospitalizations in individuals younger than 21 years from 31 states was conducted, using Agency for Healthcare Research and Quality 2021 Healthcare Cost and Utilization Project data. Analyses were conducted from February 1 to October 20, 2022.

Main outcomes and measures: Fifty complications, adverse medication events, costs, and the Social Vulnerability Index.

Results: There were 4107 individuals with MIS-C (median age, 9 [IQR, 5-13] years; 2443 [59.5%] male; 1384 [38.1%] White) and 23 686 individuals with COVID-19 without MIS-C (median age, 15 [IQR, 5-18] years; 12 878 [54.4%] female; 4605 [44.1%] White), with 1.48 (95% CI, 1.35-1.62) MIS-C hospitalizations per 100 000 children per month, ranging from 0.97 hospitalizations per 100 children for White and 1.99 hospitalizations per 100 children for Black children. Outcomes worsened as the number of organ system dysfunctions increased from 2 to 8 organs. Deaths associated with MIS-C increased from less than 1% to 5.8% (95% CI, 3.3%-8.4%) and from less than 1% to 17.2% (95% CI, 11.7%-22.7%) for COVID-19 (P = .001). Adverse medication events associated with MIS-C increased from 4.9% (95% CI, 3.8%-6.0%) to 17.8% (95% CI, 13.7%-22.0%) and from 1.2% (95% CI, 1.0%-1.3%) to 13.4% (95% CI, 8.4%-18.3%) for COVID-19. The median length of stay for MIS-C increased from 4 (IQR, 2-5) to 8 (IQR, 5-12) days and from 3 (IQR, 2-5) to 16 (IQR, 7-23) days for COVID-19. Median costs for MIS-C increased from $16 225 (IQR, $9244-$26 822) to $53 359 (IQR, $35 920-$86 882) and from $6474 (IQR, $3741-$12 103) to $98 643 (IQR, $30 675-$204 956) for COVID-19. The percentage of MIS-C cases that were in Black children doubled from 16.2% to 31.7% (P = .001) as organ dysfunction increased, remaining unchanged with COVID-19. Hospital stays for MIS-C increased by 1 day (P = .01) for Black patients compared with White patients, with Black patients moving from the bottom to top quartile of socioeconomic vulnerability, with no disparity with COVID-19.

Conclusions and relevance: In this cross-sectional study, MIS-C was more common and severe than previously reported, with more racial disparities in outcomes than were seen in patients with COVID-19. The findings of this study suggest that relying on mean outcomes for MIS-C from past studies can be misleading, since outcomes and disparities varied widely with the number of multiorgan dysfunctions.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Figueroa reported receiving personal fees from Navitas Clinical Research, Technical Resources International, The Johns Hopkins University, and Georgetown University Medical Center outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Racial and Ethnic Disparities in Risk-Adjusted Outcomes
Disparities in outcomes in patients with multisystem inflammatory syndrome in children (MIS-C) (A) vs COVID-19 (B). Whiskers represent the 95% CI. LOS indicates length of stay.
Figure 2.
Figure 2.. Socioeconomic and Racial and Ethnic Disparities in Risk-Adjusted Median Hospital Days
All multisystem inflammatory syndrome in children (MIS-C) and COVID-19 hospitalizations (patients aged <21 years) across 31 states in 2021 by low vulnerability, representing the bottom 25% of the Centers for Disease Control and Prevention Social Vulnerability Index (SVI) data (A), and high vulnerability, representing the top 25% of the SVI (B). Days are risk adjusted for age, sex, and chronic conditions. Source: Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project quarterly inpatient data and the SVI data. P values are for high and low comparisons within race and ethnicity and disease.
See this image and copyright information in PMC

Comment in

Similar articles

  • Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.
    Payne AB, Gilani Z, Godfred-Cato S, Belay ED, Feldstein LR, Patel MM, Randolph AG, Newhams M, Thomas D, Magleby R, Hsu K, Burns M, Dufort E, Maxted A, Pietrowski M, Longenberger A, Bidol S, Henderson J, Sosa L, Edmundson A, Tobin-D'Angelo M, Edison L, Heidemann S, Singh AR, Giuliano JS Jr, Kleinman LC, Tarquinio KM, Walsh RF, Fitzgerald JC, Clouser KN, Gertz SJ, Carroll RW, Carroll CL, Hoots BE, Reed C, Dahlgren FS, Oster ME, Pierce TJ, Curns AT, Langley GE, Campbell AP; MIS-C Incidence Authorship Group; Balachandran N, Murray TS, Burkholder C, Brancard T, Lifshitz J, Leach D, Charpie I, Tice C, Coffin SE, Perella D, Jones K, Marohn KL, Yager PH, Fernandes ND, Flori HR, Koncicki ML, Walker KS, Di Pentima MC, Li S, Horwitz SM, Gaur S, Coffey DC, Harwayne-Gidansky I, Hymes SR, Thomas NJ, Ackerman KG, Cholette JM. Payne AB, et al. JAMA Netw Open. 2021 Jun 1;4(6):e2116420. doi: 10.1001/jamanetworkopen.2021.16420. JAMA Netw Open. 2021. PMID: 34110391 Free PMC article.
  • Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
    Elias MD, Truong DT, Oster ME, Trachtenberg FL, Mu X, Jone PN, Mitchell EC, Dummer KB, Sexson Tejtel SK, Osakwe O, Thacker D, Su JA, Bradford TT, Burns KM, Campbell MJ, Connors TJ, D'Addese L, Forsha D, Frosch OH, Giglia TM, Goodell LR, Handler SS, Hasbani K, Hebson C, Krishnan A, Lang SM, McCrindle BW, McHugh KE, Morgan LM, Payne RM, Sabati A, Sagiv E, Sanil Y, Serrano F, Newburger JW, Dionne A; Pediatric Heart Network MUSIC Study Investigators. Elias MD, et al. JAMA Netw Open. 2023 Jan 3;6(1):e2248987. doi: 10.1001/jamanetworkopen.2022.48987. JAMA Netw Open. 2023. PMID: 36595296 Free PMC article.
  • Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, Soma VL, Maddux AB, Mourani PM, Bowens C, Maamari M, Hall MW, Riggs BJ, Giuliano JS Jr, Singh AR, Li S, Kong M, Schuster JE, McLaughlin GE, Schwartz SP, Walker TC, Loftis LL, Hobbs CV, Halasa NB, Doymaz S, Babbitt CJ, Hume JR, Gertz SJ, Irby K, Clouser KN, Cvijanovich NZ, Bradford TT, Smith LS, Heidemann SM, Zackai SP, Wellnitz K, Nofziger RA, Horwitz SM, Carroll RW, Rowan CM, Tarquinio KM, Mack EH, Fitzgerald JC, Coates BM, Jackson AM, Young CC, Son MBF, Patel MM, Newburger JW, Randolph AG; Overcoming COVID-19 Investigators. Feldstein LR, et al. JAMA. 2021 Mar 16;325(11):1074-1087. doi: 10.1001/jama.2021.2091. JAMA. 2021. PMID: 33625505 Free PMC article.
  • SARS-CoV-2 Infection and Racial Disparities in Children: Protective Mechanisms and Severe Complications Related to MIS-C.
    Kurup S, Burgess R, Tine F, Chahroudi A, Lee DL. Kurup S, et al. J Racial Ethn Health Disparities. 2022 Aug;9(4):1536-1542. doi: 10.1007/s40615-021-01092-7. Epub 2021 Jul 13. J Racial Ethn Health Disparities. 2022. PMID: 34255304 Free PMC article. Review.
  • Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.
    Panigrahy N, Policarpio J, Ramanathan R. Panigrahy N, et al. J Pediatr Rehabil Med. 2020;13(3):301-316. doi: 10.3233/PRM-200794. J Pediatr Rehabil Med. 2020. PMID: 33252101 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Centers for Disease Control and Prevention . Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). 2022. Accessed October 14, 2022. https://www.cdc.gov/mis/mis-c/hcp/index.html
    1. Verdoni L, Mazza A, Gervasoni A, et al. . An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-1778. doi:10.1016/S0140-6736(20)31103-X - DOI - PMC - PubMed
    1. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-1608. doi:10.1016/S0140-6736(20)31094-1 - DOI - PMC - PubMed
    1. Toubiana J, et al. . Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France. MedRxiv. Preprint posted online May 14, 2020. doi:10.1101/2020.05.10.20097394 - DOI
    1. Belhadjer Z, Méot M, Bajolle F, et al. . Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429-436. doi:10.1161/CIRCULATIONAHA.120.048360 - DOI - PubMed

Publication types

Supplementary concepts